MedTekon 2025

MedTekon is the flagship event of Medical Technology Association of India (MTaI). It brings together key opinion leaders from the healthcare space and adjacencies.

MedTekon 2025 hosted a line-up of insightful panel sessions which raised the calibre of the dialogue among the who’s who in the MedTech space.

Who should attend?

Policymakers, Thought Leaders in MedTech, Hospitals, Procurement Agencies, Doctors, Investors, Academicians, Research Institutions, Distributors, Consultants and Media

Why Attend MedTekon 2025?

Capture cutting edge insights from the sector
Network with decision makers and path breakers
Discover emerging trends and technologies

Read More
Chief Guest and Guest of Honour
Smt. Anupriya Patel

Union Minister of State, Ministry of Health & Family Welfare & Ministry of Chemicals and Fertilizers

Dr. V.K. Paul

Member, NITI Aayog

Guests and Speakers
Ms. Ritu Sain

Investment Commissioner, Govt. of Chhattisgarh

Mr. Aseem Sahu

Deputy Drugs Controller, CDSCO

Mr. Ajit B Chavan

Additional CEO, Government-e-Marketplace

Mr. Chinmay Dwivedi

Head MHD, Bureau of Indian Standards

Mr. Pavan Choudary

Chairman & Director General; & Managing Director, Vygon India

Event Excerpts
Our Sponsors & Partners

Gold Sponsor

Partner

Silver Sponsor

Silver

Title Sponsor

Partner
News Coverages
Indian Med Device makers face stiff test as US tariffs take effect, eyes diplomatic escape

Indian Med Device makers face stiff test as US tariffs take effect, eyes diplomatic escape

03 Apr 2025 | Super Admin User

Over the recent tariff announced by the US President, industry bodies in India have called the move a significant challenge to the sector’s growth and stakeholders have voiced to explore bilateral routes for a balanced approach to serve mutual interest. Source:- ET Healthworld

Read More
Indian medical devices industry calls USA’s 27% tariff challenge for growth

Indian medical devices industry calls USA’s 27% tariff challenge for growth

03 Apr 2025 | Super Admin User

Indian medical device manufacturers expect challenges for their growth in the United States (US) after President Donald Trump announced imposing a 27 per cent reciprocal tariff on imports from India. The new tariffs may impact India Source:- Business Standard

Read More
US harming its own citizens by putting excessive tariffs on medical technology: MTaI

US harming its own citizens by putting excessive tariffs on medical technology: MTaI

03 Apr 2025 | Super Admin User

US President Donald Trump has announced reciprocal tariffs on about 60 countries to counter higher duties imposed globally on American products. Pavan Choudary, Chairman, Medical Technology Association of India (MTaI) said that the U.S. administration’s decision to impose reciprocal tariffs does not reflect informed policymaking. Source:- Financial Express

Read More
Medtech sectors views US tariff hike as barrier to growth

Medtech sectors views US tariff hike as barrier to growth

03 Apr 2025 | Super Admin User

US President Donald Trump announced tariffs on April 2, 2025 as part of his “Liberation Day” economic plan. The tariffs include a 26 per cent reciprocal duty on Indian imports. The Trump administration exempted pharmaceutical exports from the tariff, but medical devices were not included in the package. Source:- Express Healthcare

Read More
No tariffs on Indian pharma; plays vital role in supplying affordable medicines to US

No tariffs on Indian pharma; plays vital role in supplying affordable medicines to US

03 Apr 2025 | Super Admin User

The Trump administration has exempted the Indian pharma sector from reciprocal tariffs, recognising the vital role played by the domestic industry in supplying affordable medicines across the globe, including the US, . Source:- Zee Business

Read More